SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (115)10/30/2001 1:09:29 PM
From: scaram(o)uche  Read Replies (1) of 598
 
The financing? Nigel's comments were in re. to a company selling their interest in TLRK.

It may help to get an early "snapshot" of TLRK. They were graced with $50M in early round funding, at a time when amounts that large were unheard of.

Their founders had one major mission from the start..... combine molecular biology with medicine to make big, big bucks. Shareholders are riding enormous leverage, and serious downside risk.

TLRK is old-time, rip-roaring biotech investing.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News